Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6937 - 6944 of 12091 results

Drug Makers Not Off the Hook as States Continue to Take Action to Control Drug Prices
June 29, 2017| Blog| Viewpoint

Phantom Recusal Policy Leads to Partial Summary Judgment for Plaintiffs in the Ocwen Securities Litigation
June 28, 2017| Blog| Viewpoint

Massachusetts House & Senate Tackle Marijuana
June 28, 2017| Blog| Viewpoint

Extension of U.S. Patent and Trademark Office’s Cancer Immunotherapy Pilot Program
June 28, 2017| Blog| Viewpoint

Federal Circuit Puts the Brakes on PTAB Final Written Decision For Procedural APA Violation
June 28, 2017| Blog| Viewpoint

Oregon Ramps up State Consumer Protections in an Era of Deregulation
June 28, 2017| Blog| Viewpoint

USCIS Introduces Redesigned I-485 Application Forms
June 28, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
